Search ACTG publications from 1/1/2006 to current.


Filter results by

Found 747 results
Found 747 results.


Opollo VS, Wu X, Hughes MD, et al. "HIV testing uptake among the household contacts of multidrug-resistant tuberculosis index cases in eight countries." Int. J. Tuberc. Lung Dis.. 2018;22(12):1443-1449.
Robertson K, Oladeji B, Jiang H, et al. "HIV-1 and TB Co-infection in Multinational Resource Limited Settings: Increased neurological dysfunction." Clin. Infect. Dis.. 2018.
D Salantes B, Zheng Y, Mampe F, et al. "HIV-1 latent reservoir size and diversity are stable following brief treatment interruption." J. Clin. Invest.. 2018;128(7):3102-3115.
Sharaf R, Lee GQ, Sun X, et al. "HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers." J. Clin. Invest.. 2018;128(9):4074-4085.
Bares SH, Smeaton LM, Xu A, Godfrey C, McComsey GA. "HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy." J Womens Health (Larchmt). 2018;27(9):1162-1169.
Hart SA, Vardhanabhuti S, Strobino SA, Harrison LJ. "Impact of Changes Over Time in the Stanford University Genotypic Resistance Interpretation Algorithm." J. Acquir. Immune Defic. Syndr.. 2018;79(1):e21-e29.
Shivakoti R, Gupte N, Tripathy S, et al. "Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study." BMC Med. 2018;16(1):161.
Martin MP, Naranbhai V, Shea PR, et al. "Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1." J. Clin. Invest.. 2018;128(5):1903-1912.
Kearney MF, Spindler J, Wiegand A, et al. "Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adults." PLoS ONE. 2018;13(1):e0190438.
Lidofsky A, Holmes JA, Feeney ER, et al. "Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection." J. Infect. Dis.. 2018;218(9):1394-1403.
Kapadia SN, Wu C, Mayer KH, et al. "No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305." PLoS ONE. 2018;13(12):e0206577.
Sherman KE, Rouster SD, Kang M, Umbleja T, Sterling R, Butt AA. "PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals." Dig. Dis. Sci.. 2018.
Stringer EM, Kendall MA, Lockman S, et al. "Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy." PLoS ONE. 2018;13(7):e0199555.
Torres TS, Harrison LJ, La Rosa AM, et al. "Quality of life among HIV-infected individuals failing first-line antiretroviral therapy in resource-limited settings." AIDS Care. 2018;30(8):954-962.
Torres TS, Harrison LJ, La Rosa AM, et al. "Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women." AIDS. 2018;32(5):583-593.
Riddler SA, Zheng L, Durand CM, et al. "Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART." Open Forum Infect Dis. 2018;5(10):ofy242.
Dubé MP, Chan ES, Lake JE, et al. "A Randomized, Double-Blinded, Placebo-Controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed HIV Infection." Clin. Infect. Dis.. 2018.
Wilkin TJ, Chen H, Cespedes MS, et al. "A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298." Clin. Infect. Dis.. 2018;67(9):1339-1346.
Swindells S, Gupta A, Kim S, et al. "Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003)." Int. J. Tuberc. Lung Dis.. 2018;22(9):1016-1022.
Benson CA, Andersen JW, Macatangay BJC, et al. "Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy." Clin. Infect. Dis.. 2018;67(11):1712-1719.
Hsue PY, Ribaudo HJ, Deeks SG, et al. "Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314." Clin. Infect. Dis.. 2018.
Akpa O, Miyahara S, Taiwo B, Evans S, Berzins B, Robertson K. "Similar changes in neuropsychological functioning in english and spanish speaking HIV patients." Brain Behav. 2018;8(9):e01083.
Wyles DL, Kang M, Matining RM, Murphy RL, Peters MG. "Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)." Open Forum Infect Dis. 2018;5(6):ofy103.
Kelesidis T, Kendall MA, Danoff A, Aberg JA, Currier JS, Schmidt AMarie. "Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332." Medicine (Baltimore). 2018;97(22):e10955.
Hoenigl M, Moser C, Funderburg N, et al. "Soluble Urokinase Plasminogen Activator Receptor (suPAR) is predictive of Non-AIDS Events during Antiretroviral Therapy-mediated Viral Suppression." Clin. Infect. Dis.. 2018.
Chow FC, Wilson MR, Wu K, Ellis RJ, Bosch RJ, Linas BP. "Stroke incidence is highest in women and non-Hispanic blacks living with HIV in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort." AIDS. 2018;32(9):1125-1135.
Utay NS, Kitch DW, Yeh E, et al. "Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone." J. Infect. Dis.. 2018;217(11):1770-1781.
Jennings C, Wager CG, Scianna SR, et al. "Use of External Quality Control Material for HIV-1 RNA Testing To Assess the Comparability of Data Generated in Separate Laboratories and the Stability of HIV-1 RNA in Samples after Prolonged Storage." J. Clin. Microbiol.. 2018;56(6).
Kalayjian RC, Albert JM, Cremers S, et al. "Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy." AIDS. 2018;32(17):2517-2524.